{"id":"https://openalex.org/W52267807","doi":null,"title":"Biologic therapy in erythrodermic and pustular psoriasis.","display_name":"Biologic therapy in erythrodermic and pustular psoriasis.","publication_year":2014,"publication_date":"2014-03-01","ids":{"openalex":"https://openalex.org/W52267807","mag":"52267807","pmid":"https://pubmed.ncbi.nlm.nih.gov/24595581"},"language":"en","primary_location":{"id":"pmid:24595581","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24595581","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087990097","display_name":"Ethan Levin","orcid":"https://orcid.org/0000-0002-7428-3168","observed_orcids":["https://orcid.org/0000-0002-7428-3168"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ethan C Levin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035402295","display_name":"Maya G. Debbaneh","orcid":"https://orcid.org/0000-0003-4798-3553","observed_orcids":["https://orcid.org/0000-0003-4798-3553"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maya Debbaneh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102727788","display_name":"John Y. M. Koo","orcid":"https://orcid.org/0009-0004-1005-5221","observed_orcids":["https://orcid.org/0009-0004-1005-5221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Koo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5078581958","display_name":"Wilson J. Liao","orcid":"https://orcid.org/0000-0001-7883-6439","observed_orcids":["https://orcid.org/0000-0001-7883-6439"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wilson Liao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2358,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.76533352,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"13","issue":"3","first_page":"342","last_page":"54"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erythrodermic-psoriasis","display_name":"erythrodermic psoriasis","score":0.9309999942779541},{"id":"https://openalex.org/keywords/generalized-pustular-psoriasis","display_name":"generalized pustular psoriasis","score":0.9679999947547913},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.9869999885559082},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":1.0},{"id":"https://openalex.org/keywords/anakinra","display_name":"anakinra","score":1.0},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.7570000290870667},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8230000138282776},{"id":"https://openalex.org/keywords/severe-psoriasis","display_name":"severe psoriasis","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9747070074081421},{"id":"https://openalex.org/C2777226972","wikidata":"https://www.wikidata.org/wiki/Q415343","display_name":"Etanercept","level":3,"score":0.8418796062469482},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7971638441085815},{"id":"https://openalex.org/C2778975655","wikidata":"https://www.wikidata.org/wiki/Q420305","display_name":"Ustekinumab","level":4,"score":0.7919026613235474},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.7854064702987671},{"id":"https://openalex.org/C2776907424","wikidata":"https://www.wikidata.org/wiki/Q5532501","display_name":"Generalized pustular psoriasis","level":3,"score":0.778313934803009},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.644749104976654},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6236193180084229},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5601283311843872},{"id":"https://openalex.org/C2778784858","wikidata":"https://www.wikidata.org/wiki/Q1363741","display_name":"Erythroderma","level":2,"score":0.5543003678321838},{"id":"https://openalex.org/C2911221801","wikidata":"https://www.wikidata.org/wiki/Q2742406","display_name":"Biologic Agents","level":3,"score":0.48256364464759827},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.4529822766780853},{"id":"https://openalex.org/C2781228260","wikidata":"https://www.wikidata.org/wiki/Q415411","display_name":"Anakinra","level":3,"score":0.44094857573509216},{"id":"https://openalex.org/C2778496887","wikidata":"https://www.wikidata.org/wiki/Q341500","display_name":"Acitretin","level":3,"score":0.41312241554260254},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18869176506996155},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.09247782826423645},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08692476153373718},{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.0689966082572937}],"mesh":[{"descriptor_ui":"D001691","descriptor_name":"Biological Therapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001691","descriptor_name":"Biological Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007155","descriptor_name":"Immunologic Factors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:24595581","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24595581","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},{"id":"mag:52267807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24595581","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5458504750","display_name":"Genetic Analysis of the TNF Pathway in Psoriasis","funder_award_id":"K08AR057763","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3014247083","https://openalex.org/W1823894345","https://openalex.org/W2984218665","https://openalex.org/W4408973205","https://openalex.org/W2980544439","https://openalex.org/W1973117329","https://openalex.org/W4253017376","https://openalex.org/W4385582936","https://openalex.org/W7132536654","https://openalex.org/W4415646944"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,86],"efficacy":[2,39,180],"of":[3,40,46,50,75,121,152,183],"biologic":[4,41,76,126,143,161,185],"therapy":[5,162],"in":[6,20,43,150,167],"treating":[7,168],"plaque-type":[8],"psoriasis":[9,22,51],"is":[10,15,159],"well":[11],"documented.":[12],"However,":[13],"there":[14],"less":[16],"data":[17],"for":[18,67],"use":[19,74],"other":[21,104],"subtypes,":[23],"such":[24],"as":[25],"erythrodermic":[26,80,109,169],"and":[27,38,52,94,110,136,170,181],"generalized":[28,82,111,171],"pustular":[29,83,112,172],"psoriasis.":[30,84,173],"OBJECTIVE:":[31],"We":[32,64],"sought":[33],"to":[34,53,56,78,117,164,176],"review":[35],"the":[36,44,73,122,153,157,178,184],"safety":[37,182],"medications":[42,127],"treatment":[45],"these":[47,61],"severe":[48],"subtypes":[49],"identify":[54],"strategies":[55],"help":[57],"clinicians":[58],"optimally":[59],"manage":[60],"patients.":[62,154],"METHODS:":[63],"searched":[65],"Pubmed":[66],"English":[68],"language":[69],"literature":[70,88],"that":[71,128],"assessed":[72],"medication":[77],"treat":[79,118],"or":[81,103],"RESULTS:":[85],"primary":[87],"included":[89,132],"cases":[90,92,139],"reports,":[91],"series,":[93],"open-label,":[95],"uncontrolled":[96],"trials.":[97,106],"There":[98],"were":[99,129,148],"no":[100],"head-to-head":[101],"studies":[102,189],"controlled":[105,188],"In":[107,174],"both":[108],"psoriasis,":[113],"infliximab":[114],"was":[115],"used":[116,131],"over":[119],"half":[120],"reported":[123,140,149],"cases.":[124],"Other":[125],"successfully":[130],"etanercept,":[133],"ustekinumab,":[134],"adalimumab,":[135],"anakinra.":[137],"Most":[138],"improvement":[141],"with":[142],"therapy.":[144],"Serious":[145],"adverse":[146],"events":[147],"10-12%":[151],"CONCLUSION:":[155],"Although":[156],"evidence":[158],"limited,":[160],"appears":[163],"be":[165],"effective":[166],"order":[175],"assess":[177],"comparative":[179],"medications,":[186],"larger":[187],"are":[190],"needed.":[191]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}